CDX-0158
CDX-0158 (NCT02642016; KTN0158) is a humanized anti-c-Kit/CD117 IgG1κ monoclonal antibody. CDX-0158 effectively blocks the SCF-KIT signaling pathway and inhibits mast cell activation, but due to the retention of wild-type IgG1 Fc, it can induce mast cell degranulation through FcyR cross-linking, resulting in obvious infusion reactions. CDX-0158 can be used in research related to advanced refractory gastrointestinal stromal tumors.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
体内実験
アプリケーション
ELISA, FACS, Functional assay
Product Details
-
アクセッション番号 P10721
-
別名 NCT02642016; KTN0158
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
Product Properties
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Eggel A, et al. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways. Immunol Rev. 2024;328(1):387-411. [Content Brief]
[2]. Alvarado D, et al. Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study. Allergy. 2022;77(8):2393-2403. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- CDX-0158
- NCT02642016
- KTN0158
- CDX0158
- CDX 0158
- NCT 02642016
- NCT-02642016
- KTN0158
- KTN 0158
- KTN-0158
- c-Kit
- SCFR
- CD117
- antibody-dependent cell-mediated cytotoxicity
- interferon gamma
- IFNγ-pretreated primary human mast cells
- M-07e cells
- healthy dogs
- KIT-expressing target cells
- KIT
- gastrointestinal stromal tumor patients
- apoptosis
- primary mast cells
- Inhibitor
- inhibitor
- inhibit